Scholarlink

<p>Microsurgical resection remains the gold standard in the treatment of spinal meningiomas. Available data suggest more favorable clinical outcomes compared to intracranial meningiomas. This study aims to enhance risk stratification and optimize treatment strategies by analyzing clinical and histopathological predictive factors for spinal meningiomas in a large single-center cohort.&#xa0;We present the analysis of 217 spinal meningiomas of our institutional meningioma cohort treated between October 2003 and March 2017. Clinical parameters of the patients such as sex, age, location of the meningioma and extent of resection were recorded besides histological features. Other parameters included follow-up and recurrence. The outcome parameters for spinal meningiomas were evaluated and compared with 1767 intracranial meningiomas.&#xa0;Among 217 spinal meningiomas, 80.37% (<i>n</i> = 172) were completely resected. The majority (96.31%, <i>n</i> = 209) were classified as CNS WHO grade 1. In contrast, the proportion of WHO grade 1 among intracranial meningiomas was 78.21% (<i>n</i> = 1382, <i>p</i> &lt; 0.0001). Patients with spinal meningiomas had a lower recurrence rate with 6.91% (<i>n</i> = 15), versus 23.94% (<i>n</i> = 423) of patients with intracranial meningiomas (<i>p</i> &lt; 0.0001). Multivariate analysis identified Simpson resection grade (<i>p</i> &lt; 0.0001) and higher WHO grade (<i>p</i> = 0.0156) as independent prognostic factors for risk factors for progression in spinal meningiomas. For intracranial meningiomas, male gender (<i>p</i> = 0.0106) and resection of a recurrent tumor (<i>p</i> &lt; 0.0001) were additionally identified as independent negative prognostic parameters.&#xa0;Spinal meningiomas are associated with a more favorable prognosis compared to their intracranial counterparts. The most significant and modifiable prognostic factor is the achievement of gross total resection. Given the technical complexity of surgery, spinal meningiomas should preferably be treated in high-volume centers with experienced surgeons to achieve this goal while minimizing morbidity and ensuring durable tumor control.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predictive factors in spinal meningiomas – a comparative analysis with intracranial meningiomas of a high-volume skull and base center

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Christina Fodi,
  • Hanna Gött,
  • Peter Paßlack,
  • Jens Schittenhelm,
  • Jonas Tellermann,
  • Jürgen Honegger,
  • Marcos Tatagiba,
  • Felix Behling,
  • Hannes Becker

摘要

Microsurgical resection remains the gold standard in the treatment of spinal meningiomas. Available data suggest more favorable clinical outcomes compared to intracranial meningiomas. This study aims to enhance risk stratification and optimize treatment strategies by analyzing clinical and histopathological predictive factors for spinal meningiomas in a large single-center cohort. We present the analysis of 217 spinal meningiomas of our institutional meningioma cohort treated between October 2003 and March 2017. Clinical parameters of the patients such as sex, age, location of the meningioma and extent of resection were recorded besides histological features. Other parameters included follow-up and recurrence. The outcome parameters for spinal meningiomas were evaluated and compared with 1767 intracranial meningiomas. Among 217 spinal meningiomas, 80.37% (n = 172) were completely resected. The majority (96.31%, n = 209) were classified as CNS WHO grade 1. In contrast, the proportion of WHO grade 1 among intracranial meningiomas was 78.21% (n = 1382, p < 0.0001). Patients with spinal meningiomas had a lower recurrence rate with 6.91% (n = 15), versus 23.94% (n = 423) of patients with intracranial meningiomas (p < 0.0001). Multivariate analysis identified Simpson resection grade (p < 0.0001) and higher WHO grade (p = 0.0156) as independent prognostic factors for risk factors for progression in spinal meningiomas. For intracranial meningiomas, male gender (p = 0.0106) and resection of a recurrent tumor (p < 0.0001) were additionally identified as independent negative prognostic parameters. Spinal meningiomas are associated with a more favorable prognosis compared to their intracranial counterparts. The most significant and modifiable prognostic factor is the achievement of gross total resection. Given the technical complexity of surgery, spinal meningiomas should preferably be treated in high-volume centers with experienced surgeons to achieve this goal while minimizing morbidity and ensuring durable tumor control.